Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

MYO - Myomo, Inc. Последние новости | Finranks

Home

/

MYO

M

Myomo, Inc. (MYO)

ASE – Цена в реальном времени. Валюта: USD

1.50

-0.01 (-0.99%)

Рынок открыт: Aug 12, 2026, 2:19 PM EDT

1.50

-0.01 (-0.66%)

Предыдущая сессия: Aug 11, 2026, 7:47 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Myomo Q2 Earnings Call Highlights

Myomo Q2 Earnings Call Highlights

Myomo NYSEAMERICAN: MYO reported second-quarter 2026 revenue growth of 21% as the wearable robotics company continued shifting its patient acquisition strategy toward recurring referral sources and expanded reimbursement relationships.

Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript

Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript

Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.11 per share a year ago.

Myomo Reports Second Quarter 2026 Financial and Operating Results

Myomo Reports Second Quarter 2026 Financial and Operating Results

BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2026. “I am pleased to report that the evolution of our go-to-market approach is driving positive results. Revenue of $11.7 million exceeded our expectations, with 53% of.

Видео

No Data

There is no data to display

Пресс-релизы

Myomo Reports Second Quarter 2026 Financial and Operating Results

Myomo Reports Second Quarter 2026 Financial and Operating Results

BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2026. “I am pleased to report that the evolution of our go-to-market approach is driving positive results. Revenue of $11.7 million exceeded our expectations, with 53% of.